Why doesn’t immunotherapy work for everyone?
In the last decade, immunotherapy has become a viable treatment option for many cancer patients. Unlike radiation and chemotherapy, immunotherapy does not target the cancer itself. Instead, it enables a patient’s own immune system to attack the disease. In most cases, immune-based treatments stimulate T cells, a specialized type of immune cell, to fight cancer.
Immunotherapy drugs called immune checkpoint inhibitors accomplish...
Progress in treating medullary thyroid cancer
Medullary thyroid cancer is a rare cancer diagnosed in about 1,200 patients annually in the U.S. Because it’s often a silent disease, many...
New targeted therapy and immunotherapy approaches: Phase I clinical trial developments at ESMO Virtual Congress 2020
Studying new cancer therapies through clinical trials is essential for progress in cancer care. Phase I clinical trials are designed to evaluate...
Chromosomal instability study yields possible cancer treatment approach
In cancer, there are often large-scale deletions, rearrangements or other disruptions to our genetic information, which lead to a phenomenon known as chromosomal instability. This process has long been recognized, but new discoveries are helping us to better understand its role in cancer development.
A recent study from MD Anderson researcher George Calin, M.D., Ph.D., has discovered a culprit responsible for chromosomal instability...
